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Background
Ideally, the process of annotating protein coding genes
(hereby referred to as ‘genes’) in a region of genomic DNA
involves locating the exact external and internal boundaries
of all the genes it includes and, for each, finding all the
possible transcript variants. In practice, achieving this is
very difficult in eukaryotic genomes for many reasons. First,
eukaryotic genes are generally composed of a succession of
exons and introns, which makes their structure complex and
highly variable. Second, genes cover only a small fraction of
eukaryotic genomes (30% in mammals) and exons cover an
even lower fraction (1% to 2% in mammals). Third, some
eukaryotic genomes contain many pseudogenes, which are
non-functional copies of genes sometimes nested within
genes and with similar compositions. Finally, each gene may
give rise to many different transcripts, often with minor
variations, a mechanism that modulates the function or the
spatial or temporal availability of the corresponding protein.
Despite these difficulties, precise gene annotation is crucial
for biomedical research: it is a basic requirement to link
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Abstract
Background: Accurate and automatic gene identification in eukaryotic genomic DNA is more
than ever of crucial importance to efficiently exploit the large volume of assembled genome
sequences available to the community. Automatic methods have always been considered less
reliable than human expertise. This is illustrated in the EGASP project, where reference
annotations against which all automatic methods are measured are generated by human
annotators and experimentally verified. We hypothesized that replicating the accuracy of human
annotators in an automatic method could be achieved by formalizing the rules and decisions that
they use, in a mathematical formalism.
Results: We have developed Exogean, a flexible framework based on directed acyclic colored
multigraphs (DACMs) that can represent biological objects (for example, mRNA, ESTs, protein
alignments, exons) and relationships between them. Graphs are analyzed to process the
information according to rules that replicate those used by human annotators. Simple individual
starting objects given as input to Exogean are thus combined and synthesized into complex
objects such as protein coding transcripts.
Conclusions: We show here, in the context of the EGASP project, that Exogean is currently the
method that best reproduces protein coding gene annotations from human experts, in terms of
identifying at least one exact coding sequence per gene. We discuss current limitations of the
method and several avenues for improvement.
Open Accessgenotype and phenotypes in human and model species and
generally to focus the work of biologists and bio-informa-
ticians on an essential functional part of the genome. Forty
eukaryotic genome sequences have now been completed and
each is commonly tens of millions or even billions of
nucleotides long: annotating genes in this massive amount
of data undoubtedly requires mathematical models.
Mathematical models have been proposed to automatically
locate genes in genomic DNA, either by similarity to
expressed or evolutionary conserved sequences, or by
capturing our current biological understanding of genes in
statistical algorithms, or a combination of these methods.
Despite tremendous advances, automatic gene annotations
are still considered predictions that require validation by
human experts, particularly when expensive and time
consuming experimental work will be based upon them. This
paradigm is exemplified in the ENCODE Genome Anno-
tation Assessment Project (EGASP) competition [1], where
the reference against which all the automatic methods are
measured is a set of annotations experimentally verified and
manually curated by human experts. Such high quality
reference gene annotations (also including those collated in
the Vega repository [2]) are generated by humans based on a
number of resources: cross-species sequence alignments,
mRNA sequences, ab initio predictions, and so on.
Generally, with the aid of sophisticated annotation and
curation software tools, these resources are reviewed on a
gene-by-gene basis using strict rules rooted in a deep
knowledge of both the data at hand and the biology
associated with gene expression (transcription, splicing,
translation, and so on).
Based on these observations, we were interested in designing
an automatic annotation method that explicitly establishes
the same relationships between biological objects, and
applies the same rules, as human experts. In computer
science, some such rules can be assimilated to heuristics of
the type ‘if (X) then (Y) else (Z)’. The automatic annotation
of protein coding genes may, therefore, appear deceivingly
simple and be reduced to coding the rules extracted from
biological expertise into a set of heuristics and to applying
them to the experimental evidence. In the field of gene
annotation, however, encoding human expertise is rather a
problem of untangling the body of evidence that experts
build to elect a sequence to the status of protein coding gene.
This body of evidence can be viewed as a complex network of
relationships between DNA, mRNA and protein sequences.
These relationships are difficult to formalize because
biological knowledge cannot (yet) be assimilated to a
structured list of observations based on a controlled
vocabulary. It is instead a rich and heterogeneous set of
often unconnected observations. It is also in constant
evolution and may, therefore, vary from one set of experts to
another. It does not always follow strict logical rules and
instead may rely on arbitrary variables. In the context of
gene annotation, the latter is often a consequence of a lack of
knowledge on specific aspects of gene structure and biology.
For instance, a transcript with an annotated coding region of
less than 100 amino acids is often considered too short and
not classified as coding for a protein.
Our first objective was, therefore, to design a formal
framework within which rules and biological objects may be
represented and manipulated using computers to produce
gene annotations. We then identified a number of rules and
biological objects used by human annotators and integrated
them into the framework. The resulting software tool is
called Exogean for EXpert On GEne Annotation. We believe
that this strategy is currently the only possibility to approach
the level of completeness and accuracy reached by human
experts. Here we show, in the context of the EGASP
competition of the ENCODE project, that Exogean already
performs better than any other automatic method in
identifying at least one exact coding sequence per gene.
Results
The Exogean method
Human annotators manipulate and integrate information
stemming from multiple heterogeneous sources (for example,
ab initio predictions, mRNA and expressed sequence tag
(EST) alignments, protein alignments). Each source has
specific properties and is thus treated with specific rules. For
instance, mRNA sequences from the same species that is
being annotated should align to the genome with high
similarity (98% to 100%) while protein sequences from a
different species typically align less perfectly owing to base
substitutions, insertions or deletions during evolution.
Hence, mRNA alignments are dealt with using more
stringent rules and are given more importance because they
can be aligned perfectly, while protein alignments are
typically treated with more caution. The different sources of
data will, therefore, be represented differently, and will be
processed by different heuristics.
To develop a flexible yet formal framework, we decomposed
human expertise into heuristics of two independent types:
the establishment of relationships between objects on the
one hand; and the action of connecting and merging the
objects based on these relationships on the other hand.
This independence between relationships and actions
provides the flexibility required to solve a number of
difficulties: heuristics change over time - the system must be
able to easily adapt to these changes by modifying, adding or
deleting heuristics; heuristics are applied to different
sources of information (for example, different types of
sequence alignment) - the system must be able to handle
heterogeneous sources; heuristics are themselves of different
types, whether they deal for instance with structural
concepts (properties of aligned sequences) or on prioritizing
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heuristics.
In Exogean (Figures 1 and 2), transcripts are built from
relatively simple objects (sequence alignments) into more
complex structures. Throughout the manuscript, therefore,
the term transcript model will designate transcripts at any
level of complexity, from basic sequence alignments to the
final structure that represents the predicted functional
mRNA (Figure 2). Following this we define that heuristics
of the type ‘relationship’ will always be established between
two transcript models of the same level of complexity. The
fact that relationships may be directional (can be represen-
ted as an arrow between two objects) greatly simplifies the
actions (see below) and is based on the directionality of the
DNA molecule and, hence, of transcription itself. Relation-
ships are thus directed by default, unless otherwise
specified.
To represent transcript models and relationships, and to
apply actions on the former using the latter, we use directed
acyclic coloured multigraphs (DACMs; Figures 1 and 2). In
such graphs, nodes are transcript models and multiple edges
between nodes are the relationships. In its current version,
Exogean uses three DACMs, each with increasingly complex
and accurate transcript models (nodes) and different
relationships (edges). While DACM1 is built from the
original sources of information given to Exogean (mRNA
and/or protein alignments), its output will be the basis of
DACM2, and DACM3 will be built from the output of
DACM2. To proceed from one DACM to the next, Exogean
performs a graph reduction. The first step in reducing a
graph involves the definition of a set of relationships (edges)
that will represent a certain path. Then Exogean finds all the
paths of maximal length in the DACM, which results in
combining the different nodes located on each of these
paths. The nodes collected along a maximal path together
form a more complex object (transcript model) that will be a
new node ready for processing in the next DACM. Edges are
then built between these nodes, and this constitutes a new
DACM that, in turn, can be reduced. In summary, Exogean
automates the annotation protocol followed by human
experts by iteratively building edges (making relationships)
and subsequently reducing DACMs (taking actions based on
these relationships). Before and after the three core DACMs,
Exogean also applies heuristics to respectively prepare the
data for transcript modeling, and to identify coding
sequence (CDS) within transcripts (Figure 1).
The EGASP assessment
Exogean is one of 20 automatic methods that were
compared in the EGASP project [1] (see Materials and
methods). In brief, each method predicted protein coding
transcripts in 31 regions of the human genome totaling
about 21 Mb. Independently, a group of experts (the Havana
group at the Sanger Institute [3]) annotated the same
regions using manual curation and experimental validation
and identified 296 genes that were considered as reference
against which all the automatic methods were compared. We
refer to this set of genes as the GENCODE annotations [4].
The comparison between GENCODE annotations and
Exogean predictions is summarized in Table 1. Except for the
DNA sequence itself, the only source of information used by
Exogean to predict transcripts were human mRNA and
mouse protein sequence alignments (see Materials and
methods). Exogean predictions are evaluated both if they
overlap and if they exactly match a GENCODE annotation
(see Materials and methods).
Overlapping predictions
Two standard measures to evaluate the accuracy of
predictions against a reference are sensitivity (percentage of
annotations identified) and specificity (percentage of
predictions that identify an annotation). In the overlap
evaluation, Exogean consistently detects GENCODE coding
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Figure 1
Overview of the Exogean methodology. Exogean annotations are based
on protein and/or mRNA alignments. Protein sequences come from a
different species than that of the DNA to be annotated (for example,
mouse protein to annotate human genes), while the mRNAs originate
from tissues of the species being annotated. (a) These alignments are first
processed to remove artifacts using heuristics. (b) The core of the
method is the directed acyclic multigraph (DACM) component, which
builds transcripts of increasing complexity in three iterative steps using a
second set of heuristics. (c) The transcripts are then examined to identify
a complete or a partial coding sequence (CDS), and (d) a last filter applies
a last set of rules to remove pseudogenes.
Preprocessing
mRNAs
(species s1)
Proteins 
(species s2)
Preprocessing
CDS identification
Final pseudogene models Final gene models with
multiple transcripts
DACM 1
Single molecule clustering
(Level 2 transcript modelling)
Multi type multi molecule clustering 
(Level 4 transcript modelling)
DACM 3
Single type multi molecule clustering 
(Level 3 Transcript modelling)
DACM 2
(a)
(c)
(b)
(d) Quality filter
Level 1 transcript models
DACM  Expert
Annotation
Genomic sequence 
(species s1)
Alignment Alignmentnucleotides, exons, transcripts and CDS with more than 80%
sensitivity and 94% specificity. Of particular interest is the
identification of transcripts and genes, where Exogean
predicts less than 3% false positives (15 transcripts out of 513
predicted) corresponding to 8 genes that do not overlap a
Havana gene. We investigated in more details the reasons
why Exogean predicted these sequences as genes, since some
may potentially represent new CDS. Two predictions corres-
pond to retro-transposable elements (one L1 and one LTR)
that are both supported by at least one mRNA aligned at
these positions. One prediction corresponds to the H19
maternally imprinted non-coding RNA on chromosome 11,
where Exogean nevertheless predicts a 356 amino acid protein
sequence across its 5 exons spanning more than 50% of the
length of the RNA. Another prediction is a GENCODE
putative gene directly downstream of H19 supported by a
single human placental mRNA that, upon manual inspec-
tion, displays no pseudogene characteristics but shows no
similarity to any known protein. GENCODE ‘putative’ genes
are not considered bona fide coding transcripts in this
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Figure 2
Example of transcript modeling from a set of protein and
mRNA alignments using DACMs. (a) The DACM input are
mRNA (r1...r6) and protein (p1, p2) sequences that have
been aligned to a genomic sequence S. The individual local
alignments are each a level 1 transcript model (L1TMs) and
constitute the nodes of a graph DACM1. (b) This graph has
three possible directed edges: same_molecule,
maximal_intron_size, and genomic_molecule_order. Each
corresponds to a different relationship that connects two
nodes if they respectively: are alignments produced by the
same mRNA or same protein; are separated by a distance
smaller than a user defined threshold (for example, 75
kilobases); and are collinear on the molecule of origin
(mRNA or protein) and the genomic DNA. There are nine
maximal paths along the three combined edges, which
reduce DACM1 into the nine nodes (r1 to r6 and p1’,p1’’,
p2) of a graph DACM2, each representing a level 2
transcript model (L2TM). Note that the reduction of
DACM1 splits nodes p1,1 to p1,5 into two DACM2 nodes
(p1’ and p1) because of the absence of a
genomic_molecule_order edge between p1,3 and p1,4. 
(c) DACM2 has three possible edges, inclusion, extension
(for mRNAs) and genomic_overlap (for proteins), which
respectively connect two nodes if: they overlap and their
overlapping introns are identical; they overlap and their
overlapping introns are identical but the second node also
extends the first in 3’; and the span of the two nodes have
overlapping genomic coordinates. The reduction follows
either the ‘extension’ rule for mRNAs edges or the
genomic_overlap protein edge and produces here the five
nodes of graph DACM3 (mRNA nodes R1 to R3 and
protein nodes P1 and P2), which represent level 3
transcript models (L3TMs). (d) DACM3 has two possible
edges, genomic_overlap and compatible_splicing_structure,
which connect (combines) protein and mRNA transcript
models if they respectively have overlapping genomic
coordinates and if the protein transcript model does not
have any exons in introns of the mRNA transcript model.
To reduce the graph, Exogean first identifies the path that
contains both edges and from these, the reduction consists
in grouping all nodes that are connected to the same RNA
node. This generates the three nodes of a graph DACM4
(RP1 to RP3), which represent level 4 transcript models
(L4TMs). These L4TMs are the final transcript models
generated by the DACM expert annotation. (e) Graphical
representation of the DACM expert annotation output: the
final transcript models RP1 to RP3 are represented on the
genomic sequence S. No information has been lost during
the three graph reductions. Note that transcript models
produced by the DACM component of Exogean are not yet
final, and will be further examined and potentially extended
when looking for splicing and start/stop signals.
DACM EXPERT ANNOTATION 
DACM 3
DACM 2
DACM EXPERT ANNOTATION
DACM 1
r2
r6
p1
r1
r3
r4
r5
p2
= DACM 2 nodes
Level 2 transcript models
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DACM 3 REDUCTION
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P1
R3 R2
P2
R1
a) Nodes: level 3 transcript models
b) Edges: relations between level 3 transcript models
b) Edges: relations between level 2 transcript models
a) Nodes: level 1 transcript models
b) Edges: relations between level 1 transcript models
= Level 1 transcript models
= DACM 1 nodes
mRNA (ri) and protein (pj) alignements
(a)
a) Nodes: level 2 transcript models
c) Type of paths for reduction:
c) Type of paths for reduction:
c) Type of paths for reduction:
(e)
(d)
(c)
(b)
OUTPUT
r2,3
r3,2 r3,1
r2,1
r3,3 r3,4
r6,3 r6,1
r5,1
r4,1
p2,1 p2,2 p2,3
p1,4
r6,4
p1,5
r6,2
r5,2
r4,2
r5,3
r3,3 r3,2
p1,1 p1,2 p1,3
r1,2 r1,1
r2,2
r1
r4 r3
r2
r5
same_molecule
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genomic_molecule_order
extension for mRNAs
inclusion for mRNAs
genomic_overlap for proteins
− extension for mRNAs
− genomic_overlap for proteins
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r2 r1 r3 r4 r5 r6 p1’ p1’’ p2
P2 P1 R3
DACM 2 REDUCTION
R1 R2
r6 p1’ p1’’
p2
RP2 RP3 RP1
same_molecule AND maximal_intron_size
AND genomic_molecule_order
genomic_overlap AND compatible_splicing_structure evaluation, and it is thus considered an incorrect Exogean
prediction. Finally, four predictions correspond to clear
cases of pseudogenes that Exogean did not identify as such.
In conclusion, across the 31 Encode regions tested, Exogean
predicts only six true false positive genes that do not overlap
GENCODE annotations, and two neighboring genes that are
expressed in the form of RNAs but are either putative CDS or
known non-coding functional RNA.
Conversely, Exogean misses 53 GENCODE protein-coding
genes out of 296 (18%). Examination of each case revealed
eight possible causes, listed in Table 2. The most prominent
reason for which Exogean fails to predict a gene overlapping
a GENCODE annotation is when such genes are organized in
clusters (33 genes missed). In these situations, homologous
mouse proteins invariably produce alignments to most genes
in the cluster because they all share a high sequence
similarity. If one such mouse protein bridges two or more
neighboring genes by producing alignments that are
contiguous both in the protein sequence and in the genomic
DNA, this contiguity will not be eliminated by Exogean
provided it continues to comply with the other rules.
Consequently, Exogean defined transcripts spanning the
entire cluster and the CDS found in each prediction only
covers one or perhaps two GENCODE annotations, resulting
in most genes in the cluster being missed. Most cases (26 out
of 33) concern the Encode region ENm009, which contains
an olfactory receptor gene cluster. Clearly, the rules currently
implemented in Exogean for exploiting protein alignment
need revisiting to address such cases, which theoretically
should not pose a major problem and thus provide a rich
avenue for improvement. The other causes for false negative
predictions each concern fewer cases (between 1 and 8). For
instance, Havana annotated 42 transcripts in 29 genes with
a CDS smaller than 300 nucleotides. Exogean currently does
not predict CDS that would produce a protein with less than
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Table 1
Exogean performances in identifying GENCODE coding sequences
Measure Sensitivity (%) Specificity (%) Exogean correct Exogean wrong GENCODE missed GENCODE total
Overlap
Nucleotides 84.18 94.33 371,369 22,301 69,791 441,160
Exons 90.12 94.94 2,495 133 273 2764
Transcripts 89.37 97.08 498 15 151 649
Genes 82.09 96.35 211 8 53 296
Exact
Nucleotides 84.18 94.33 371,369 22,301 69,791 441,160
Exons 79.34 83.45 2,193 435 571 2764
Transcripts 42.53 52.44 267 237 373 649
Genes 63.18 80.82 187 32 109 296
Table 2
Diagnostic for GENCODE genes missed by Exogean
Class of diagnostic Number of cases Description of the cause
1 33 Proteins matching multiple neighboring genes in clusters
2 8 GENCODE CDS size below 300 nucleotides
3 3 GENCODE CDS interrupted by the boundaries of the Encode region
4 2 Insufficient evidence to predict the gene
5 3 Protein evidence eliminated by Exogean
6 1 mRNA evidence eliminated by Exogean 
7 2 Intron donor/acceptor sites not accepted by Exogean
8 1 mRNA evidence was misaligned with genomic DNA100 amino acids, which prevented predictions overlapping
eight of these GENCODE genes. Three GENCODE genes
were not predicted because they are interrupted by the limits
of the Encode region. Since we filtered out as potentially
unreliable any evidence that was truncated by the boun-
daries of Encode regions, Exogean was unable to predict
transcripts in these genes. The remaining eight GENCODE
genes that were not predicted by Exogean are due to rules
implemented in the program that are slightly too stringent,
resulting either in the elimination of some evidence or in the
inability to identify rare forms of intron donor/acceptor
sites. These rules can thus probably be refined further.
Exactly matching predictions
The difficulty in automatically annotating protein-coding
genes in eukaryotic DNA lies not so much in identifying
predictions that at least partially overlap the coding
sequence of each real gene but rather in identifying the
precise positions of the coding sequence of every transcript,
that is, the start codon, all the internal exon boundaries if
they exist, and the stop codon. In designing Exogean, we
have focused on maintaining a high specificity in order to
obtain a strong and reliable baseline annotation, with as few
compromises as possible on sensitivity. This is reflected in
Exogean’s specificity in exact gene CDS predictions
(Table 1), which is higher than any other method by a large
margin: no other method shows more than 70% specificity
while Exogean shows more than 80% specificity (Figure 3).
Does this come at the cost of a low sensitivity? A group of
seven methods including Exogean show a distinctly better
sensitivity (between 63% and 73%) than all the others (below
50%). Exogean’s sensitivity (63%) is not, therefore, notably
affected by the quest for a high specificity. In fact, four
GENCODE genes are uniquely identified by Exogean
(supported by both mouse proteins and human mRNAs) and
by no other method from the same category. Altogether,
based on the average between specificity and sensitivity (a
standard measure to compare different methods [5,6]) for
exact gene CDS predictions, Exogean comes in first position
when ranking all the methods that participated in the
EGASP competition (Figure 3).
Like Havana, Exogean is able to predict several alternative
transcripts per gene: Exogean and Havana identify on
average 2.34 and 2.19 isoforms per gene, respectively.
Interestingly, while its sensitivity for detecting transcripts is
the second highest across all methods, Exogean does not
predict exactly matching transcripts with the same high
specificity as for genes (Table 1). To explain this apparent
contradiction, we were interested to see if a specific category
S7.6 Genome Biology 2006, Volume 7, Supplement 1, Article S7 Djebali et al. http://genomebiology.com/2006/7/S1/S7
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Figure 3
Exogean outperforms all other automatic methods confronted during EGASP. Histogram of the performances in terms of specificity (Sp, grey), sensitivity
(Sn, white), and average between specificity and sensitivity ((Sn+Sn)/2, black) for all methods designed to predict protein-coding sequences in the EGASP
competition. The values were provided by the EGASP organizers, and are based on predictions matching at least one coding sequence (CDS) exactly for
each Havana annotated gene (known or novel). The methods are ranked left to right from best to worse average between Sn and Sp.
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(Sn+Sp)/2
Sp
Snof GENCODE transcripts is better predicted than others.
Indeed, out of 267 exact transcripts predicted by Exogean, a
remarkable 266 correspond to GENCODE transcripts that
are complete, that is, where a start and a stop codon have
been found. The single remaining exact Exogean transcript
matches one of the 194 incomplete GENCODE transcripts.
This result has two important consequences: the first is the
conclusion that Exogean reproduces GENCODE annotations
much better when the latter are complete transcripts. The
second is the suggestion that a fraction of the complete
Exogean transcripts overlapping incomplete GENCODE
transcripts, and thus not showing exact matches, might be
correct. Indeed, there are 23 GENCODE genes that only
include incomplete transcripts, and complete Exogean
transcripts overlap 11 of these 23 genes. It is thus not
excluded that Exogean is able to completely and correctly
annotate genes that were partially annotated by Havana. If
this was the case, one would expect discrepancies between
Exogean and GENCODE transcripts to occur more often at
the end of transcripts, where arbitrary end points are more
frequent. Figure 4 shows indeed that initial and terminal
exons are less well identified exactly by Exogean than
internal ones, although Exogean does overlap these external
exons with the same sensitivity as internal ones.
An important factor that likely explains why Exogean
transcripts are exact in complete GENCODE transcripts but
not in partial ones is that Exogean only uses human mRNA
and mouse protein alignments, while Havana also includes
human ESTs among other additional sources. When a
GENCODE annotation is only supported by ESTs, then
Exogean will often predict a different transcript or no
transcript at all, depending on the conservation of the
corresponding protein in mouse. This affects mainly
incomplete GENCODE transcripts because ESTs typically
cover only parts of complete transcripts of a given gene.
Conversely, if mRNA evidence exists for a gene, then
Exogean and Havana will both use it and are thus more
likely to predict the same corresponding transcript, which is
more likely to be complete because mRNAs tend to cover the
entire length of transcripts. We are currently formulating
heuristics that will also allow Exogean to take ESTs into
account.
Finally, Exogean predictions show the highest average
number of exons per transcript (9.8) compared to Havana
(8.28) and all other methods (below 8.6). One factor
contributing to this high figure is that Exogean predicts
fewer transcripts with few exons than Havana (Figure 5). In
contrast, Havana and Exogean predict a remarkably similar
number of transcripts with many exons (more than 9 exons)
and this is accompanied by a higher sensitivity in correct
predictions (Figure 6) for these particular transcripts. Here
also, the different sources of evidence used by the two
strategies probably explain these observations: transcripts
with many exons are more likely to be predicted based on
mRNA alignments, while shorter transcripts probably reflect
more EST-based alignments, simply because ESTs are
generally shorter than mRNAs.
An improved version of Exogean (post-EGASP)
Since the EGASP experiment, we have addressed many of
the limitations described above in a new version of Exogean.
Major areas of improvement have focused on refining the
rules to untangle protein alignments in clusters of
paralogous genes, and in the definition of the CDS of tran-
scripts. These rules have a direct positive impact on sensi-
tivity, with very little consequence on specificity; sensitivity
in exact GENCODE CDS identification increases to 72.64%
and specificity remains essentially stable at 79.30%. The
average between these two measures is 75.97%, which
demonstrates a substantial improvement over the version
used in EGASP (72.00%). Using this version, we tested the
influence of the nature of the information provided to
Exogean. Indeed, human mRNAs generally provide a high
specificity and precise exon boundaries but only cover a
subset of genes, while each mouse protein tends to identify a
broad spectrum of genes in human (paralogs), albeit with
fuzzy boundaries. The complementarity of these two sources
of information is confirmed when each is used individually
and then in combination. Human mRNAs alone provide very
specific predictions for a substantial fraction of GENCODE
CDSs (sensitivity and specificity for exact CDS prediction are
64.86% and 82.11%, respectively) and mouse proteins
provide little sensitivity and little specificity on exact CDS
predictions (17.23% and 50.00%, respectively). But
combining both sources yields the performances described
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Figure 4
GENCODE and Exogean agree more often on exact boundaries of
internal rather than external exons. Histogram of Exogean sensitivity and
specificity in identifying the exact boundaries (left) and overlapping
boundaries (right) of Havana initial, internal and terminal exons. While
Exogean more or less predicts overlapping exons with similar specificities
for initial, internal and terminal exons, this is not the case for exactly
matching exons: Exogean internal exons are much more specific (89%)
than external ones (62% and 72%).
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initialabove for the new version of Exogean, with a sharp increase
in sensitivity and a minor decrease in specificity compared
to the use of human mRNAs only. Of note, the sensitivity of
Exogean predictions increases by 8% when mouse proteins
are added to human mRNAs. The reason stems from a rule
that forbids the use of single exon transcript models based
solely on human mRNAs, whereas many such genes are
recovered by mouse proteins.
Discussion
Conclusions from previous studies aiming at comparing
automatic annotation methods in eukaryotic genomes have
often been limited by the availability of a large and reliable
reference dataset. In this respect, the EGASP assessment
project has been a unique opportunity to rigorously measure
how well current strategies replicate meticulous and detailed
protein coding gene annotations on a large and varied set of
genomic regions in a blind test [1] (see Materials and
methods). A commonly accepted standard for annotating
genes is to consider that at least one coding transcript must
be entirely and exactly identified [7]. Using this measure,
Exogean is the method that currently best replicates
reference annotations out of 20 methods tested in EGASP.
In particular, Exogean is the most specific by a large
measure (12% more than the next best), which reflects our
S7.8 Genome Biology 2006, Volume 7, Supplement 1, Article S7 Djebali et al. http://genomebiology.com/2006/7/S1/S7
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Figure 5
Histogram of the number of Exogean and Havana predicted transcripts as a function of their respective number of exons. For transcripts with large
numbers of exons (more than 9), Exogean and Havana predict remarkably similar numbers of transcripts.
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Figure 6
Histogram of Exogean’s sensitivity in predicting exact GENCODE
transcripts as a function of the number of exons in the latter. Clearly,
GENCODE transcripts with larger numbers of exons are better identified
than smaller transcripts.
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)initial objective when designing the method. In addition, out
of all methods with good performances, Exogean is also the
most consistent across the 31 ENCODE regions [1]. This
suggests that Exogean would be the most likely method to
reproduce its performances on a different set of human
genomic regions. Because 8 out of 10 genes annotated by
Exogean are correct, one possible use of Exogean is to
accelerate annotations by human experts, especially since
the methodology behind Exogean intuitively follows the
same logic. To assist in this task, Exogean generates (in
addition to the positions of transcripts and their sequences)
information on each predicted gene and transcript that
summarizes their structure, the evidence used, the problems
and conflicts encountered and the solutions applied. Human
experts may continue from there and use additional rules,
resources and experiments to correct or confirm the
automatic predictions.
While Exogean is specific, its sensitivity could be improved
in several ways. First, the annotations that we produced for
the EGASP assessment relied solely on two sources of
alignments: human mRNA sequences and proteins predicted
in the mouse genome. It is thus not unexpected that other
participating methods that rely on a wider range of resources
(human ESTs, mRNAs from other species, conserved genomic
DNA) identify more genes, and we are currently designing
rules to integrate some of these resources as well. We also
show that current rules designed to exploit mouse protein
alignments fail when human genes are in clusters, such as
the olfactory receptor gene cluster. The EGASP experience
was extremely useful in helping to uncover such limitations,
many of which have been addressed in a new version of
Exogean.
Automatic annotation methods have traditionally used
statistical models to capture properties of genes and
annotate them in genomic DNA, either alone [8,9] or in
combination with evidence from other sources [10-13].
Exogean departs from these approaches in that it only relies
on rules extracted from human expertise, and as such does
not need to train on a set of known genes to ‘learn’ their
statistical properties. Directed acyclic graphs (DAGs), the
component used in the Exogean strategy to store and
manipulate the information, have already been used in the
context of gene annotation, albeit differently. The program
AIR [14] uses DAGs where exons are nodes and edges are
introns. ESTGenes [15] uses similar DAGs to Exogean but
with a unique edge between nodes, whereas multiple edges
are used in Exogean’s multigraphs. One advantage of using
DAGs as in ESTGenes or Exogean is the strict independence
that can be maintained between the data and the heuristics
applied to the data.
Translating human expertise for gene annotation into a
computational framework could be generalized if an
appropriate language was developed. The formalization that
is at the core of Exogean, namely the DACM algorithm, can
be seen as a natural starting point for developing such a
language. If successful, this approach could lead to a more
general and expressive method to integrate any rule that
biologists use to synthesize information about biological
objects in order to create more complex objects. Such
approaches could potentially be of great use in the future.
Materials and methods
The Exogean software
Exogean is written in Ocaml [16]. Precompiled executables
are available for several platforms [17]. Exogean is currently
able to annotate eukaryote protein coding genes based on
alignments with proteins from a different species and/or
mRNAs from the same species. Input files with the
alignments must be provided in one of several possible
formats (psl, gff or exf, the latter being a simple format
developed for Exogean). For the EGASP assessment,
Exogean used proteins from the mouse International Protein
Index database (March 2005 version containing 42,799
protein sequences) and human mRNA from EMBL (March
2005 release, containing 213,695 mRNA sequences) aligned
by BLAT [18]. If protein alignments are used, a fasta
formatted file with the protein sequences must also be
provided. Finally, a configuration file is required where a
large number of parameters pertaining to the rules used by
Exogean are specified. Given that the alignments are
computed, Exogean is fast since the entire human genome is
annotated in approximately 100 minutes on a single 3 GHz
processor with 1 Gb memory. A formal description of the
Exogean method will be described elsewhere.
The EGASP assessment
To place in their context the results described here, we
briefly summarize the conditions of EGASP [1]. EGASP was
organized by the GENCODE [19] group of the ENCODE
project [20] and the aims were twofold: to evaluate how well
automatic methods are able to reproduce manual and
experimental gene annotation of the human genome; and to
assess how complete our current knowledge is of the gene
content of the human genome. A set of 31 regions of the
human genome from the ENCODE project totaling 21.5 Mb
of DNA were used by 14 groups to predict protein coding
genes. After submitting the predictions, a workshop [21] was
organized to confront the prediction and the annotations
from the Havana group [3] at the Sanger Institute. The
Havana group annotates genes by combining information
from a variety of sources using human expertise and
experimental validations (designated here as the GENCODE
annotations [4]). All the figures for sensitivity and specificity
used for Table 1 and Figure 3 are those provided by the
EGASP organizers based on these comparisons. When
necessary (Table 1, Figures 4 and 6, and text) additional
results for Exogean were computed using the Eval software
[22], kindly provided by the organizers. In the overlap mode,
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Exogean prediction is counted as true positive.
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